News

News

AstraZeneca Plans £650 Million Investment in UK

07.03.2024 -

AstraZeneca, whose CEO Pascal Soriot has been critical of the UK business environment for the life sciences industry in the past, wants to invest a large sum at its...

News

Perstorp Becomes Sole Owner of Chinese Joint Venture

06.03.2024 -

Swedish chemical producer Perstorp has bought out its minority partner in the joint venture (JV) Shandong Perstorp Chemical Co. (formerly Shandong Fufeng Perstorp...

Strategy & Management

Breakthrough Supply Chains for the Pharmaceutical Industry

06.03.2024 -

The pharmaceutical industry is a truly global and complex network of ingredients and materials suppliers, manufacturers, distributors for a variety of products ranging...

News

AkzoNobel Completes Capacity Expansion at Vietnam Multi-site

05.03.2024 -

AkzoNobel has completed a significant investment project at its production facility in Bac Ninh province, Vietnam, aimed at strengthening the company’s position in Asia...

News

Large-Scale Production Announced by Epsilogen and Lonza for Ovarian Cancer Treatment

05.03.2024 -

Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out...

News

Evonik Divests Superabsorbents Business to ICIG

05.03.2024 -

Evonik is selling its superabsorbents business to the International Chemical Investors Group (ICIG). According to Evonik, the purchase price is in the low triple-digit...

News

ADNOC Completes Acquisition of 24.9% Stake in OMV

04.03.2024 -

Abu Dhabi National Oil Company (ADNOC) has completed the acquisition of a 24.9% stake in Austrian energy group OMV from Mubadala, the sovereign wealth fund of the United...

News

Novo Nordisk and Neomorph to Develop Molecular Glue Drugs

04.03.2024 -

US biotechnology company Neomorph signed a $1.46 billion licensing agreement with Novo Nordisk to discover, develop and commercialize molecular glue degraders.